XP Chemistries AB (SE:XPC)
:XPC
Want to see SE:XPC full AI Analyst Report?
Top Page
XP Chemistries AB
(XPC)
Select Model
Select Model
Rating:47Neutral
Price Target:
kr0.18
▲(0.00% Upside)
Action:Reiterated
Date:05/30/26
The score is held down primarily by weak financial performance—large operating losses and ongoing cash burn—despite a low-risk, debt-free balance sheet. Technicals are modestly supportive in the short term but not strong enough to offset fundamentals, and valuation is constrained by negative earnings and no dividend yield data.
Positive Factors
Conservative balance sheet (no debt)
A zero-debt capital structure materially lowers financial distress risk and preserves flexibility to fund operations or restructure financing as needed. Over a 2-6 month horizon this reduces default risk and gives management optionality to support a turnround without immediate debt service constraints.
Negative Factors
Persistent operating losses
Deep and persistent operating losses indicate the current business model does not cover overhead and operating expenses. Over a multi-month horizon this continues to erode reserves and equity, forcing hard choices on cost cuts, strategic pivots, or capital raises before profitable scale is achieved.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet (no debt)
A zero-debt capital structure materially lowers financial distress risk and preserves flexibility to fund operations or restructure financing as needed. Over a 2-6 month horizon this reduces default risk and gives management optionality to support a turnround without immediate debt service constraints.
Read all positive factors
XP Chemistries AB (XPC) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr54.00M
Dividend YieldN/A
Average Volume (3M)792.79K
Price to Earnings (P/E)―
Beta (1Y)0.58
Revenue GrowthN/A
EPS GrowthN/A
CountrySE
Employees2
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.04
Shares Outstanding313,976,300
10 Day Avg. Volume516,841
30 Day Avg. Volume792,795
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.97
Price to Sales (P/S)109.05
P/FCF Ratio-3.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)kr7.86M
XP Chemistries AB Business Overview & Revenue Model
Company Description
As a biotechnology company, XP Chemistries AB specializes in the development and production of forest-derived capsaicin and its related compounds. Its diverse offerings include ingredients for animal nutrition, components for cosmetic formulations...
How the Company Makes Money
null...
XP Chemistries AB Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
20
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 357.76K | 327.39K | 283.94K | 663.68K | 1.06M | 279.39K |
| Gross Profit | 149.62K | 127.68K | 328.97K | 335.61K | 488.98K | 149.56K |
| EBITDA | -9.88M | -9.05M | -7.52M | -8.70M | -8.73M | -5.01M |
| Net Income | -9.25M | -8.52M | -7.13M | -8.04M | -7.92M | -4.55M |
Balance Sheet | ||||||
| Total Assets | 36.25M | 38.07M | 22.72M | 27.20M | 30.65M | 34.39M |
| Cash, Cash Equivalents and Short-Term Investments | 12.44M | 15.23M | 2.15M | 7.83M | 15.20M | 21.40M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.77M | 1.13M | 1.16M | 1.51M | 1.58M | 3.09M |
| Stockholders Equity | 34.48M | 36.94M | 21.56M | 25.69M | 29.07M | 31.30M |
Cash Flow | ||||||
| Free Cash Flow | -10.11M | -9.18M | -8.53M | -11.41M | -11.80M | -8.13M |
| Operating Cash Flow | -9.38M | -8.85M | -7.69M | -9.08M | -9.85M | -4.99M |
| Investing Cash Flow | -762.23K | -332.30K | -834.96K | -2.33M | -1.95M | -6.31M |
| Financing Cash Flow | 19.53M | 22.26M | 2.85M | 4.04M | 5.60M | 32.70M |
XP Chemistries AB Peers Comparison
UnderperformOutperform
Sector (61)
SE:XPC
XP Chemistries AB
0.17
-0.08
-30.36%
DE:NC4
Nexam Chemical Holding AB
0.24
-0.07
-23.57%
DE:5L80
Svenska Aerogel Holding AB
0.03
-0.04
-57.53%
DE:284
Serstech AB
0.02
-0.03
-54.00%
DE:A6X
aXichem AB Class A
0.08
-0.13
-61.32%
DE:0CF
OrganoClick AB
0.01
-0.14
-92.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.